Clinical Trial

Using Artificial Intelligence to Help Doctors Identify Different Skin Conditions and Improve Patient Care

Study acronym: LegitHealthSAN
Completed
View on ClinicalTrials.gov →
Summary
This study aims to determine if an artificial intelligence (AI) medical device can help doctors more accurately identify a wide variety of skin conditions and improve the efficiency of patient consultations. While many patients visit primary care for skin issues, general doctors may sometimes have different opinions from specialists, which can lead to delays in getting the right treatment. The researchers hypothesized that using the AI tool would increase the true diagnostic accuracy of healthcare professionals for multiple skin conditions. To test this, 16 doctors (including 10 general practitioners and 6 dermatologists) evaluated 29 different medical images. For each case, the doctors followed a structured process: * Initial Assessment: Doctors first gave a diagnosis based only on the patient's image and medical history. * AI Support: Doctors were then shown the AI's top five suggested diagnoses and confidence levels to see if they wished to adjust their final decision. * Clinical Utility: Doctors also indicated if the patient required a specialist referral and if the case could be handled through a remote (online) consultation. The primary question the study tried to answer was whether AI support could significantly improve correct diagnoses across 13 different types of skin pathologies-ranging from common rashes to skin cancer-while also making the consultation process faster and more effective for both doctors and patients.
Trial Details
NCT Number NCT07428954
Lead Sponsor AI Labs Group S.L
Conditions Dermatitis, Melanoma (Skin Cancer), Alopecia, Urticaria, Granuloma Annulare, Seborrheic Keratoses, Herpes, Tinea +5 more
Enrollment 16 participants
Start Date 2024-06-01
Primary Completion 2024-10-10 (estimated)
Study Completion 2024-10-10 (estimated)
Updated on ClinicalTrials.gov 2026-02-24